TWiV 1310: Clinical update with Dr. Daniel Griffin

In this episode of TWiV, Vincent Racaniello and guest Dr. Daniel Griffin provide a comprehensive clinical update on current viral threats and public health developments. The discussion begins with a lighthearted yet impactful conversation about the 'five-second rule' in surgical settings, highlighting a study showing that even brief floor contact contaminates medical implants, urging replacement over disinfection. The hosts then address ongoing public health concerns, including an FDA alert for raw cheddar cheese linked to an E. coli outbreak, and the troubling rise of vaccine misinformation—such as fears of 'canine autism' from rabies vaccines. A major focus is on the growing body of evidence that vaccines, particularly high-dose flu and shingles vaccines, significantly reduce the risk of Alzheimer’s dementia and other chronic diseases, challenging the anti-vaccine narrative. The episode also covers the emergence of the SARS-CoV-2 BA.3.2 variant, with early detection in the U.S. and concerns over immune escape, though the overall trend remains downward. Long COVID research is explored, with mixed results on Paxlovid and promising findings on fluvoxamine for fatigue. The hosts emphasize the importance of vaccination, testing, and timely treatment, especially for travelers and vulnerable populations.